2004
DOI: 10.1016/s0140-6736(04)16320-4
|View full text |Cite
|
Sign up to set email alerts
|

Fertility preservation in women undergoing cancer treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
47
0
3

Year Published

2007
2007
2013
2013

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(50 citation statements)
references
References 3 publications
0
47
0
3
Order By: Relevance
“…IVM is safe and costeffective especially when it is applied to women with polycystic ovary syndrome (PCOS) [3]. Occasionally, it could also be applied to poor responders and cancer patients [18].…”
Section: Introductionmentioning
confidence: 99%
“…IVM is safe and costeffective especially when it is applied to women with polycystic ovary syndrome (PCOS) [3]. Occasionally, it could also be applied to poor responders and cancer patients [18].…”
Section: Introductionmentioning
confidence: 99%
“…1). Similarly, after vitrification and warming, in vitro-matured oocytes displayed significantly greater DNA fragmentation than in vivo-matured oocytes based on the presence and length of the comet tail (98.7% vs. 53.6% and 101.4 AE 3.5 mm vs. 16 …”
Section: Dna Fragmentation Of Vitrified and Warmed Oocytesmentioning
confidence: 99%
“…Furthermore, ovarian stimulation may not be feasible for patients who must undergo gonadotoxic treatment without any delay. A novel and attractive fertility preserving strategy for these patients is retrieval of immature oocytes without gonadotropin stimulation followed by in vitro maturation (IVM) and subsequent cryopreservation of the in vitro-matured oocytes (16,17).…”
mentioning
confidence: 99%
“…Hormone stimulation followed by oocyte aspiration, in vitro fertilization (IVF), and embryo cryopreservation is the most common approach for preserving fertility in female cancer patients prior to chemotherapy or radiation [1][2][3][4][5]. However, hormone stimulation requires a delay in cancer treatment, may be contraindicated in patients with hormone-sensitive malignancies, and is not an option for prepubertal girls.…”
Section: Introductionmentioning
confidence: 99%